Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 25983-13-5 | MDL No. : | MFCD00078575 |
Formula : | C8H4Cl2N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | AVBSIKMUAFYZAV-UHFFFAOYSA-N |
M.W : | 231.04 | Pubchem ID : | 1845 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 55.21 |
TPSA : | 65.72 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.67 cm/s |
Log Po/w (iLOGP) : | 0.99 |
Log Po/w (XLOGP3) : | 1.46 |
Log Po/w (WLOGP) : | 1.52 |
Log Po/w (MLOGP) : | 1.76 |
Log Po/w (SILICOS-IT) : | 3.47 |
Consensus Log Po/w : | 1.84 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.72 |
Solubility : | 0.439 mg/ml ; 0.0019 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.45 |
Solubility : | 0.827 mg/ml ; 0.00358 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.38 |
Solubility : | 0.00959 mg/ml ; 0.0000415 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.84 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 80484-00-0 ]
6-Chloro-1-methyl-3,4-dihydroquinoxalin-2(1H)-one
Similarity: 0.90
[ 183500-94-9 ]
1-(3-Chlorophenyl)piperazin-2-one hydrochloride
Similarity: 0.82
[ 50610-32-7 ]
N,N'-(2-Chloro-1,4-phenylene)diacetamide
Similarity: 0.75
[ 7160-22-7 ]
N-(3,4-Dichlorophenyl)pivalamide
Similarity: 0.73
[ 80484-00-0 ]
6-Chloro-1-methyl-3,4-dihydroquinoxalin-2(1H)-one
Similarity: 0.90
[ 183500-94-9 ]
1-(3-Chlorophenyl)piperazin-2-one hydrochloride
Similarity: 0.82
[ 50610-32-7 ]
N,N'-(2-Chloro-1,4-phenylene)diacetamide
Similarity: 0.75
[ 7160-22-7 ]
N-(3,4-Dichlorophenyl)pivalamide
Similarity: 0.73
[ 80484-00-0 ]
6-Chloro-1-methyl-3,4-dihydroquinoxalin-2(1H)-one
Similarity: 0.90
[ 1910-90-3 ]
6-Bromoquinoxaline-2,3(1H,4H)-dione
Similarity: 0.66
[ 91895-29-3 ]
6,7-Difluoroquinoxaline-2,3(1H,4H)-dione
Similarity: 0.64
[ 80636-30-2 ]
3,3-Dimethyl-3,4-dihydroquinoxalin-2(1H)-one
Similarity: 0.63